Nobuhiko Yui Selected Research

polyrotaxane

1/2023	Suppressed Migration and Enhanced Cisplatin Chemosensitivity in Human Cancer Cell Lines by Tuning the Molecular Mobility of Supramolecular Biomaterials.
10/2021	Tissue Adhesion-Anisotropic Polyrotaxane Hydrogels Bilayered with Collagen.
10/2018	Polyrotaxane-based systemic delivery of β-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuhiko Yui Research Topics

Disease

6	Neoplasms (Cancer) 02/2024 - 10/2018
6	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2022 - 03/2014
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 01/2018
2	Carcinoma (Carcinomatosis) 02/2015 - 03/2013
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Atherosclerosis 11/2022
1	Inflammation (Inflammations) 11/2022
1	Osteoporosis 09/2022
1	Bone Diseases (Bone Disease) 07/2022
1	Tissue Adhesions 10/2021
1	Phototoxic Dermatitis (Phototoxicity) 12/2017
1	Macular Degeneration (Age-Related Maculopathy) 12/2017
1	Leukemia 03/2015
1	Atrial Fibrillation 12/2007
1	Shock 12/2007
1	Cysts 04/2006
1	Endometriosis 04/2006

Drug/Important Bio-Agent (IBA)

11	Rotaxanes (Rotaxane)IBA 02/2024 - 03/2014
9	CyclodextrinsIBA 02/2024 - 04/2015
6	AcidsIBA 03/2023 - 01/2016
6	CholesterolIBA 01/2023 - 03/2014
3	polyrotaxaneIBA 01/2023 - 10/2018
2	HydrogelsIBA 10/2021 - 04/2006
2	PolymersIBA 01/2018 - 07/2017
1	Peptides (Polypeptides)IBA 02/2024
1	cyclic arginine-glycine-aspartic acid peptideIBA 02/2024
1	arginyl-glycyl-aspartic acidIBA 02/2024
1	IntegrinsIBA 02/2024
1	Drug CarriersIBA 03/2023
1	Biocompatible Materials (Biomaterials)IBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	LipopolysaccharidesIBA 11/2022
1	CarbamatesIBA 07/2022
1	calcium phosphateIBA 07/2022
1	CollagenIBA 10/2021
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	maleimideIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	A2-E (N-retinylidene-N-retinylethanolamine)IBA 12/2017
1	Retinaldehyde (Retinal)IBA 12/2017
1	CytokinesIBA 12/2017
1	Poloxamer (Poloxamer 407)IBA 07/2017
1	Ethylene Glycol (Monoethylene Glycol)IBA 03/2015
1	triethylene glycol dimethacrylate (TEGMA)IBA 03/2015
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 02/2015
1	LuciferasesIBA 03/2013
1	Small Interfering RNA (siRNA)IBA 03/2013
1	Hyaluronic Acid (Hyaluronan)IBA 04/2006
1	Danazol (Azol)FDA LinkGeneric 04/2006

Therapy/Procedure

4	Therapeutics 02/2024 - 07/2017
1	Drug Therapy (Chemotherapy) 01/2020
1	Electric Countershock (Cardioversion) 12/2007